| Literature DB >> 32134208 |
Liang-Kung Chen1,2,3, An-Chun Hwang1,2,3, Wei-Ju Lee2,3,4, Li-Ning Peng1,2,3, Ming-Hsien Lin1,2,3, David L Neil5, Shu-Fang Shih6, Ching-Hui Loh2,3,7, Shu-Ti Chiou8,9.
Abstract
BACKGROUND: Frailty is the pre-eminent exigency of aging. Although frailty-related impairments are preventable, and multidomain interventions appear more effective than unimodal ones, the optimal components remain uncertain.Entities:
Keywords: Cognitive; Community; Elder empowerment; Healthy aging; Malnutrition; Multidomain intervention; Outcome; Physical frailty
Mesh:
Year: 2020 PMID: 32134208 PMCID: PMC7296266 DOI: 10.1002/jcsm.12534
Source DB: PubMed Journal: J Cachexia Sarcopenia Muscle ISSN: 2190-5991 Impact factor: 12.910
Figure 1Efficacy and Empowerment Studies: participant selection, randomization, and disposition. ADL, activities of daily living.
Baseline characteristics of the Efficacy Study and Empowerment Study participant groups
| Characteristics: data show mean ± SD [number] |
|
| |||||
|---|---|---|---|---|---|---|---|
| Total ( | Health education ( | Standard multidomain ( | Total ( | Standard multidomain ( | Enhanced multidomain ( | ||
|
| |||||||
| Age (years) | All | 75.1 ± 6.3 | 74.9 ± 6.2 | 75.3 ± 6.4 | 75.9 ± 7.1 | 76.3 ± 7.6 | 75.5 ± 6.6 |
| ≥75 | 532 (49.2) | 262 (49.2) | 270 (49.3) | 236 (53.6) | 111 (52.9) | 125 (54.3) | |
| Sex (female) | 740 (68.7) | 332 (62.4) | 408 (74.5) | 368 (83.6) | 177 (84.3) | 191 (83.0) | |
| Education (years) | 6.6 ± 4.5 | 6.4 ± 4.4 | 6.7 ± 4.5 | 6.2 ± 4.7 | 7.1 ± 4.8 | 5.3 ± 4.5 | |
| Urban residence | 529 (48.9) | 247 (46.3) | 282 (51.4) | 215 (48.9) | 100 (47.6) | 115 (50.0) | |
| Current tobacco smoker | 58 (5.4) | 41 (7.7) | 17 (3.1) | 5 (1.1) | 1 (0.5) | 4 (1.7) | |
| Current alcohol consumer | 155 (14.3) | 83 (15.6) | 72 (13.1) | 40 (9.1) | 20 (9.5) | 20 (8.7) | |
|
| |||||||
| Hypertension | 556 (51.4) | 266 (49.9) | 290 (52.8) | 231 (52.6) | 103 (49.3) | 128 (55.7) | |
| Diabetes mellitus | 256 (23.7) | 135 (25.3) | 121 (22.0) | 94 (21.4) | 48 (22.9) | 46 (20.0) | |
| Cardiovascular disease | 232 (21.4) | 123 (23.1) | 109 (19.9) | 102 (23.2) | 50 (23.8) | 52 (22.6) | |
| Stroke | 41 (3.8) | 15 (2.8) | 26 (4.7) | 14 (3.2) | 10 (4.8) | 4 (1.7) | |
| Malignancy | 39 (3.6) | 18 (3.4) | 21 (3.8) | 17 (3.9) | 7 (3.3) | 10 (4.3) | |
|
| |||||||
| MoCAadj | 20.1 ± 5.8 | 19.8 ± 5.5 | 20.5 ± 5.8 | 19.9 ± 6.4 [435] | 20.4 ± 6.5 [205] | 19.4 ± 6.4 | |
| Visuospatial executive | 2.6 ± 1.7 | 2.5 ± 1.7 | 2.7 ± 1.7 | 2.7 ± 1.6 | 2.8 ± 1.7 | 2.7 ± 1.6 | |
| Naming | 2.3 ± 0.9 | 2.3 ± 0.9 | 2.4 ± 0.9 | 2.0 ± 1.1 [435] | 2.2 ± 1.0 [205] | 1.9 ± 1.1 | |
| Concentration | 4.4 ± 1.6 | 4.4 ± 1.6 | 4.4 ± 1.6 | 4.4 ± 1.7 | 4.6 ± 1.6 | 4.2 ± 1.7 | |
| Language | 1.7 ± 1.0 | 1.6 ± 1.0 | 1.8 ± 1.0 | 1.7 ± 1.0 | 1.7 ± 1.0 | 1.7 ± 0.9 | |
| Abstract | 0.7 ± 0.8 | 0.6 ± 0.8 | 0.7 ± 0.8 | 0.6 ± 0.8 | 0.7 ± 0.8 | 0.6 ± 0.7 | |
| Delayed recall | 2.3 ± 1.7 | 2.2 ± 1.6 | 2.3 ± 1.7 | 2.3 ± 1.8 | 2.4 ± 1.9 | 2.2 ± 1.7 | |
| Orientation | 5.3 ± 1.2 | 5.3 ± 1.1 | 5.4 ± 1.1 | 5.1 ± 1.3 | 5.1 ± 1.3 | 5.1 ± 1.2 | |
|
| |||||||
| Frailty status | Robust | 374/1058 (35.3) | 177/526 (33.7) | 197/532 (37.0) | 184/425 (43.3) | 81/203 (39.9) | 103/222 (46.4) |
| Prefrail | 605/1058 (57.2) | 307/526 (58.4) | 298/532 (56.0) | 207/425 (48.7) | 109/203 (53.7) | 98/222 (44.1) | |
| Frail | 79/1058 (7.5) | 42/526 (8.0) | 37/532 (7.0) | 34/425 (8.0) | 13/203 (6.4) | 21/222 (9.5) | |
| CHS frailty score | 1.0 ± 1.0 [1058] | 1.1 ± 1.0 [526] | 1.0 ± 1.0 [532] | 0.9 ± 1.0 [425] | 0.9 ± 0.9 [203] | 0.9 ± 1.0 [222] | |
| Handgrip strength (kg) | 22.7 ± 8.3 [1075] | 23.1 ± 9.0 [530] | 22.3 ± 7.6 [545] | 21.9 ± 7.0 [436] | 21.7 ± 6.9 [208] | 22.0 ± 7.2 [228] | |
| Gait speed (m/s) | 1.0 ± 0.3 [1066] | 0.9 ± 0.3 [528] | 1.0 ± 0.3 [538] | 1.1 ± 0.3 [435] | 1.1 ± 0.4 [208] | 1.1 ± 0.3 [227] | |
| Physical activity (MET) | 14.3 ± 16.9 [1077] | 14.9 ± 18.5 [532] | 13.7 ± 15.1 [545] | 15.3 ± 17.3 [438] | 15.5 ± 17.9 [209] | 15.1 ± 16.7 [229] | |
|
| |||||||
| GDS‐5 | 0.4 ± 0.9 [1079] | 0.4 ± 0.9 | 0.4 ± 0.9 [546] | 0.4 ± 0.8 | 0.4 ± 0.8 | 0.4 ± 0.8 | |
| Depressive mood (GDS‐5 ≥2) | 96 (8.9) | 45 (8.4) | 51 (9.3) | 39 (8.9) | 20 (9.5) | 19 (8.3) | |
| Nutrition status (MNA‐SF) | 13.2 ± 1.2 [1073] | 13.2 ± 1.2 [532] | 13.1 ± 1.3 [541] | 13.3 ± 1.0 [433] | 13.2 ± 1.0 [208] | 13.3 ± 1.0 [225] | |
| Malnutrition (MNA‐SF ≤11) | 96/1073 (8.9) | 41/532 (7.7) | 55/541 (10.2) | 29/433 (6.7) | 16/208 (7.7) | 13/225 (5.8) | |
| Instrumental ADL | 7.3 ± 1.2 [1077] | 7.2 ± 1.2 | 7.4 ± 1.1 | 7.5 ± 1.1 | 7.5 ± 1.1 | 7.4 ± 1.2 | |
ADL, activities of daily living; CHS, Cardiovascular Health Study; GDS‐5, five‐item Geriatric Depression Scale; MET, metabolic equivalent of task; MNA‐SF, Mini‐Nutritional Assessment short‐form; MoCAadj, Montreal Cognitive Assessment (adjusted cut‐off).
If fewer than the entire group.
Statistically significant between‐group difference by Student's t‐test.
Figure 2Mean changes from baseline performance. (A) Physical domains; (B) functional domains; and (C) cognitive domains. CHS, Cardiovascular Health Study; MET, metabolic equivalent of task; IADL, instrumental activities of daily living; MoCAadj, Montreal Cognitive Assessment (adjusted cut‐off). * P < 0.05; ** P < 0.01; *** P < 0.001; vertical bars indicate standard error.
Figure 3Intervention effects on physical and functional performance. (A) Efficacy Study; (B) Empowerment Study. CHS, Cardiovascular Health Study; MET, metabolic equivalent of task. Horizontal bars indicate 95% confidence intervals at 6 months (blue) and 12 or 9 months (orange).
Figure 4Intervention effects on cognitive performance. (A) Efficacy Study; (B) Empowerment Study. Horizontal bars indicate 95% confidence intervals at 6 months (blue) and 12 or 9 months (orange).